Medicine composition for preventing and curing infantile cerebral palsy
A technology for children with cerebral palsy and a composition is applied in the field of pharmaceutical compositions for prevention and treatment of children with cerebral palsy and its preparation field, and can solve the problems that there is no effective medicine for the treatment of children with cerebral palsy.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0035] Embodiment 1: the pharmaceutical composition and preparation method thereof of preventing and treating infantile cerebral palsy
[0036]The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating cerebral palsy in children are: 3475g of chrysanthemum root 3440g of hydrangea root 3440g of emodin diglucoside 150g of liquiritigenin C121g and 1260g of japonica japonica;
[0037] Preparation:
[0038] (1) According to the ratio of raw materials, take worm fruit mustard, hydrangea root, emodin diglucoside, lilycyrrhizin C, and japonica japonica, mix them evenly, and use ethanol with a concentration of 22.5% by weight as a solvent, in 31.5°C warm immersion extraction, the number of extractions is 30 times, each extraction time is 0.5 hours, and the amount of solvent used each time is 26.5 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A to recover etha...
Embodiment 2
[0041] Embodiment 2: the pharmaceutical composition and preparation method thereof of preventing and treating infantile cerebral palsy
[0042] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating cerebral palsy in children are: 3500g of Echinocarpus hydrangea root, 3410g of emodin diglucoside, 158g of liquiritigenin C118g, and 1280g of Scutellaria japonicus;
[0043] Preparation:
[0044] (1) According to the ratio of raw materials, take worm fruit mustard, hydrangea root, emodin diglucoside, lilycyrrhizin C, and japonica japonica, mix them evenly, and use ethanol with a concentration of 22.5% by weight as a solvent, in 31.5°C warm immersion extraction, the number of extractions is 30 times, each extraction time is 0.5 hours, and the amount of solvent used each time is 26.5 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A to recover ethanol , ...
Embodiment 3
[0047] Embodiment 3: the pharmaceutical composition and preparation method thereof of preventing and treating infantile cerebral palsy
[0048] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating cerebral palsy in children are as follows: 3450g hydrangea root, 3470g emodin methyl ether diglucoside, 142g schizoglycyrrhizin C124g, 1240g pagoda japonica;
[0049] Preparation:
[0050] (1) According to the ratio of raw materials, take worm fruit mustard, hydrangea root, emodin diglucoside, lilycyrrhizin C, and japonica japonica, mix them evenly, and use ethanol with a concentration of 22.5% by weight as a solvent, in 31.5°C warm immersion extraction, the number of extractions is 30 times, each extraction time is 0.5 hours, and the amount of solvent used each time is 26.5 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A to recover ethanol , concent...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com